The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor

Pui Ying Chan1, Diana Alexander1, Ishan Mehta1

  • 1Wellcome Sanger Institute, Hinxton, UK.

Nature Genetics
|July 4, 2025
PubMed

Insights

Researchers identified a new therapeutic target for metastatic uveal melanoma and other cancers. The study found that targeting the CDS2 gene, especially when CDS1 expression is low, disrupts cancer cell survival.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Metastatic uveal melanoma presents limited therapeutic options.
  • Understanding genetic dependencies is crucial for developing new treatments.

Purpose of the Study:

  • To identify monogenic and digenic dependencies in uveal melanoma using CRISPR-Cas9 screening.
  • To explore the therapeutic potential of identified genetic interactions across various cancers.

Main Methods:

  • Genome-wide CRISPR-Cas9 screening in ten human uveal melanoma cell lines.
  • Analysis of single-gene and paired-gene CRISPR libraries.
  • In vivo validation of synthetic lethal interactions and gene essentiality.

Main Results:

  • Identified 76 uveal melanoma-specific essential genes and 105 synthetic lethal gene pairs.
  • Validated CDP-diacylglycerol synthase 2 (CDS2) as a dependency when CDP-diacylglycerol synthase 1 (CDS1) is underexpressed.
  • Demonstrated CDS1/CDS2 synthetic lethality in vivo, showing CDS2 knockout disrupts phosphoinositide synthesis, increases apoptosis, and CDS1 re-expression rescues fitness.

Conclusions:

  • The CDS1/CDS2 axis represents a synthetic lethal interaction and a potential therapeutic target in uveal melanoma.
  • This interaction is also essential in other tumor types with low CDS1 expression, suggesting broader applicability.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
15.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K